Skip to Content
Søg Menu

Andrea Apolo

Results from Study of Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma

/ Andrea Apolo
ASCOGU24Blærecancer Play the Video 02:02
Thomas Powles

Patient-Reported Outcomes of Belzutifan versus Everolimus in Patients with Previously Treated Advanced Renal Cell Carcinoma

/ Thomas Powles
ASCOGU24Nyrecancer Play the Video 01:59

ASCO GU 2024: A Combination of Cabozantinib and Atezolizumab is Promising for Advanced Prostate Cancer Patients with Poor Prognoses

/ Sofie Pohl
ASCOGU24Prostatacancer

Drug Sensitivity Screening to Guide Clinical Decisions for Hematologic Cancers

/ Sigrid S. Skånland
AMLCLL

ASCO GU 2024: Updated Results from AVENANCE – Real-World Effectiveness of Avelumab in Patients with Advanced Urothelial Carcinoma

/ Sofie Pohl
ASCOGU24Gynækologisk cancer
Philippe Barthelemy

Real-World Data on Avelumab as 1L Maintenance Treatment

/ Philippe Barthélémy
ASCOGU24Blærecancer Play the Video 02:48
Jeanny B. Aragon-Ching

JAVELIN Bladder 100 Trial: Strong Avelumab Maintenance Efficacy in High BMI Patients

/ Jeanny B. Aragon-Ching
ASCOGU24BMIBlærecancer Play the Video 02:40
Maha H. A. Hussain

Data from the BRCAAway Study Confirms Better PFS & Efficacy with a Combination of Olaparib + Abiraterone Prednisone

/ Maha H. A. Hussain
ASCOGU24Prostatacancer Play the Video 03:10
Neeraj Agarwal

CONTACT-2: Cabozantinib + Atezolizumab for Patients with Metastatic Castration-Resistant Prostate Cancer

/ Neeraj Agarwal
ASCOGU24Prostatacancer Play the Video 05:04

Adenosine as a Modulator of Neuropathic Pain in Preclinical and Clinical Settings

/ Lars Arendt-Nielsen / Stine N. Hansen / Henrik Klitgaard
Smerter
Back to top